Showing results (1041-1050 of 2,642) with videos related to

Sort By:
Pageof 265
Hematology (Amsterdam, Netherlands)|February 23, 2016
Comparison of clinical trial versus non-clinical trial treatment outcomes of childhood acute lymphoblastic leukemia using comparable regimensWasil Jastaniah, Naglla Elimam, Khalid Abdalla, et al.
Hematology (Amsterdam, Netherlands)|February 13, 2016
Combination of low-dose imatinib plus nilotinib for the treatment of chronic-phase chronic myeloid leukaemia after imatinib failureDavid Gómez-Almaguer, Roxana Saldaña-Vázquez, Luz Tarín-Arzaga, et al.
Hematology (Amsterdam, Netherlands)|February 13, 2016
Change in plasma a disintegrin and metalloprotease with thrombospondin type-1 repeats-13 and von Willebrand factor levels in venous thromboembolic patientsBulent Karakaya, Anil Tombak, Mehmet Sami Serin, et al.
Hematology (Amsterdam, Netherlands)|February 25, 2016
More about low-dose rituximab and plasma exchange as front-line therapy for patients with thrombotic thrombocytopenic purpuraAlberto Vazquez-Mellado, Myrna Pequeño-Luévano, Olga Graciela Cantu-Rodriguez, et al.
Hematology (Amsterdam, Netherlands)|September 3, 2014
Impact of educational programme regarding chelation therapy on the quality of life for B-thalassemia major childrenOmayma Abu Samra, Wafaa Auda, Heba Kamhawy, et al.
Hematology (Amsterdam, Netherlands)|August 23, 2014
Reduced-intensity stem cell allografting for PNH patients in the eculizumab era: The Mexican experienceAlejandro Schcolnik-Cabrera, Nancy Labastida-Mercado, Laura Samantha Galindo-Becerra, et al.
Hematology (Amsterdam, Netherlands)|July 9, 2014
Central nervous system bleeding in pediatric patients with factor XIII deficiency: a study on 23 new casesMajid Naderi, Shaban Alizadeh, Ahmad Kazemi, et al.
Hematology (Amsterdam, Netherlands)|July 14, 2016
CD34 Selection and EX Vivo Expansion of Haemopoietic Progenitor Cells: A Review of Laboratory MethodologyT L Holyoake, M J Alcorn, L J Richmond
Hematology (Amsterdam, Netherlands)|July 14, 2016
Macrophage Inflammatory Protein-1 Alpha: A Paradox?A N Parker, I B Pragnell
Pageof 265